SpectraCure
Develops a minimally invasive treatment system for internal solid tumors like prostate cancer.
SPEC | ST
Overview
Corporate Details
- ISIN(s):
- SE0007158118
- LEI:
- 549300U3BMSZ5VGYC283
- Country:
- Sweden
- Address:
- GASVERKSGATAN, 1, 222 29 Lund
- Website:
- https://spectracure.com/en/
Description
SpectraCure is a medical technology company developing a minimally invasive, next-generation treatment system for internal solid tumors. The company's primary focus is on providing a highly precise, focal therapy for localized prostate cancer, targeting both primary tumors and recurrent cancer after previous radiation therapy. The system is designed to destroy cancer cells with high precision while minimizing damage to surrounding healthy tissue. Clinical trials for the treatment are underway at leading cancer clinics in North America and Europe. The technology platform has the potential to be adapted for other solid tumors, including those in the breast, pancreas, and the head and neck region, aiming to offer a more individualized and effective treatment solution.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all SpectraCure filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for SpectraCure
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for SpectraCure via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
